Fulgent Genetics Inc FLGT

US Health Care

$16.55 ▼ -18.11% ($-3.66)

⬇️ Below Yest. Low ⚡ High Volume

Open $17.33

Prev Close $20.21

Day Range $16.05 – $17.51

52W Range $13.46 – $31.04

Market Cap $470.03M

Beta 0.92

EPS (TTM) $-2.40

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2016-09-28
Shares Out.	28,400,000
Website	fulgentgenetics.com/ ↗
Phone	13026587581
Employees	1,315
Revenue	$71.1M
Gross Profit	$21.5M
Net Income	-$25.3M
Free Cash Flow	-$113.2M
Total Assets	$1.16B
Total Liabilities	$112.2M
Equity	$1.04B

About Fulgent Genetics Inc

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

Fulgent Genetics Inc is a publicly traded company under the ticker symbol FLGT on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.